🚀 VC round data is live in beta, check it out!
Pfizer India Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pfizer India and similar public comparables like Wockhardt, Ultragenyx, Nektar Therapeutics, Bavarian Nordic and more.
Pfizer India Overview
About Pfizer India
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company has only one segment which is Pharmaceuticals and it operates in domestic market.
Founded
1950
HQ
Employees
1.6K
Website
Sectors
Financials (LTM)
EV
$2B
Pfizer India Financials
Pfizer India reported last 12-month revenue of $273M and EBITDA of $97M.
In the same LTM period, Pfizer India generated $97M in EBITDA and $83M in net income.
Revenue (LTM)
Pfizer India P&L
In the most recent fiscal year, Pfizer India reported revenue of $266M and EBITDA of $117M.
Pfizer India expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $273M | XXX | $266M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $159M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 60% | XXX | XXX | XXX |
| EBITDA | $97M | XXX | $117M | XXX | XXX | XXX |
| EBITDA Margin | 36% | XXX | 44% | XXX | XXX | XXX |
| EBIT Margin | 38% | XXX | 34% | XXX | XXX | XXX |
| Net Profit | $83M | XXX | $83M | XXX | XXX | XXX |
| Net Margin | 30% | XXX | 31% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Pfizer India Stock Performance
Pfizer India has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Pfizer India's stock price is $53.57.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.5% | XXX | XXX | XXX | $1.81 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPfizer India Valuation Multiples
Pfizer India trades at 7.9x EV/Revenue multiple, and 22.3x EV/EBITDA.
EV / Revenue (LTM)
Pfizer India Financial Valuation Multiples
As of April 19, 2026, Pfizer India has market cap of $2B and EV of $2B.
Equity research analysts estimate Pfizer India's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pfizer India has a P/E ratio of 29.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 7.9x | XXX | 8.1x | XXX | XXX | XXX |
| EV/EBITDA | 22.3x | XXX | 18.5x | XXX | XXX | XXX |
| EV/EBIT | 21.1x | XXX | 24.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 13.7x | XXX | XXX | XXX |
| P/E | 29.5x | XXX | 29.6x | XXX | XXX | XXX |
| EV/FCF | 26.3x | XXX | 25.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pfizer India Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Pfizer India Margins & Growth Rates
Pfizer India's revenue in the last 12 month grew by 9%.
Pfizer India's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Pfizer India's rule of 40 is 45% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pfizer India's rule of X is 60% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Pfizer India Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 36% | XXX | 44% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | (17%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 45% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 60% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 32% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Pfizer India Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pfizer India | XXX | XXX | XXX | XXX | XXX | XXX |
| Wockhardt | XXX | XXX | XXX | XXX | XXX | XXX |
| Ultragenyx | XXX | XXX | XXX | XXX | XXX | XXX |
| Nektar Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Bavarian Nordic | XXX | XXX | XXX | XXX | XXX | XXX |
| SK Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pfizer India M&A Activity
Pfizer India acquired XXX companies to date.
Last acquisition by Pfizer India was on XXXXXXXX, XXXXX. Pfizer India acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Pfizer India
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPfizer India Investment Activity
Pfizer India invested in XXX companies to date.
Pfizer India made its latest investment on XXXXXXXX, XXXXX. Pfizer India invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Pfizer India
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pfizer India
| When was Pfizer India founded? | Pfizer India was founded in 1950. |
| Where is Pfizer India headquartered? | Pfizer India is headquartered in India. |
| How many employees does Pfizer India have? | As of today, Pfizer India has over 1K employees. |
| Is Pfizer India publicly listed? | Yes, Pfizer India is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Pfizer India? | Pfizer India trades under PFIZER ticker. |
| When did Pfizer India go public? | Pfizer India went public in 1999. |
| Who are competitors of Pfizer India? | Pfizer India main competitors are Wockhardt, Ultragenyx, Nektar Therapeutics, Bavarian Nordic. |
| What is the current market cap of Pfizer India? | Pfizer India's current market cap is $2B. |
| What is the current revenue of Pfizer India? | Pfizer India's last 12 months revenue is $273M. |
| What is the current revenue growth of Pfizer India? | Pfizer India revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Pfizer India? | Current revenue multiple of Pfizer India is 7.9x. |
| Is Pfizer India profitable? | Yes, Pfizer India is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Pfizer India? | Pfizer India's last 12 months EBITDA is $97M. |
| What is Pfizer India's EBITDA margin? | Pfizer India's last 12 months EBITDA margin is 36%. |
| What is the current EV/EBITDA multiple of Pfizer India? | Current EBITDA multiple of Pfizer India is 22.3x. |
| What is the current FCF of Pfizer India? | Pfizer India's last 12 months FCF is $83M. |
| What is Pfizer India's FCF margin? | Pfizer India's last 12 months FCF margin is 30%. |
| What is the current EV/FCF multiple of Pfizer India? | Current FCF multiple of Pfizer India is 26.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.